Evidence-based coverage of pharmaceutical development, regulatory affairs, and biotech innovation
A whirlwind of development is swirling through the corridors of healthcare, from diagnosis to treatment and management. It's a thrilling time to be part of this tech-infused era, with clinical devices
By Megan Liu, Digital Health Reporter
In today's rapidly advancing world, biotechnology has emerged as a powerful force, propelling medical science into uncharted territories and promising a brighter future for healthcare. This multidisci
By Dr. Eleanor Vance, Regulatory Affairs Editor
Amidst a burgeoning body of research, we're continually unravelling new facets of the versatile drug ketamine. A case in point is recent studies indicating another feather in ketamine's cap: treating
By Tom Okafor, Clinical Trials Correspondent
"Old age is not a disease - it is strength and survivorship, triumph over all kinds of vicissitudes and disappointments, trials and illnesses." - Maggie Kuhn. As a seasoned medical professional and bi
By Tom Okafor, Clinical Trials Correspondent
As the world becomes increasingly reliant on pharmaceuticals to treat a wide range of diseases, the importance of drug research and development (R&D) continues to grow. In recent years, there have
By Tom Okafor, Clinical Trials Correspondent
The quest for eternal youth has been a central theme in human history, from the mythological stories of ancient cultures to the cutting-edge scientific research of today. In recent years, medical adva
By James Whitfield, Manufacturing & Supply Chain Writer
In the fast-paced world of biotech, emerging companies are always looking for ways to stand out and make their mark. One key strategy they're using is to form strategic partnerships with other compani
By Dr. Eleanor Vance, Regulatory Affairs Editor
The pharmaceutical industry has seen a significant rise in the demand for biologics, which are drugs produced from living organisms. As the demand for biologics continues to grow, so does the need for
By Dr. Eleanor Vance, Regulatory Affairs Editor
The National Health Service (NHS) has recently introduced a new pharmacy plan aimed at reducing the length of stay for patients in hospitals. The plan seeks to streamline the discharge process for pat
By Priya Raghavan, Biotech & Markets Analyst
After 13 years of research, Dr David Sinclair and his team have made a breakthrough discovery regarding ageing. Sinclair, a genetics professor at Harvard Medical School and co-director of the Paul F.
By Dr. Eleanor Vance, Regulatory Affairs Editor
Lymphoma cancer is a type of cancer that affects the lymphatic system, which is responsible for fighting infections and diseases. While there are several types of lymphoma, the two main categories are
By Tom Okafor, Clinical Trials Correspondent
In the highly competitive world of pharmaceuticals, companies are constantly looking for the next big breakthrough drug. The quest for new treatments can be a risky and expensive endeavour, with no gu
By Tom Okafor, Clinical Trials Correspondent
Subscribe to our weekly pharmaceutical intelligence digest
We use cookies and analytics to understand how the site is used and to keep the service free. Choose Accept All to allow this, or Essential Only to use just the cookies we need to keep the site working. You can change your choice any time in our Cookie Policy